Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Farmers Insurance
US Department of Justice
Healthtrust
Mallinckrodt
UBS
Daiichi Sankyo
Cerilliant
Citi

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,859,623

« Back to Dashboard

Summary for Patent: 8,859,623
Title:Methods and compositions of stable phenylephrine formulations
Abstract: The invention is directed to methods and compositions of stabilizing phenylephrine formations. The composition has good time-dependent stability at low temperature and has no change in its outward appearance even after having been stored at least 6 months.
Inventor(s): Witham; Patrick H. (Eugene, OR), Machiraju; Sailaja (Beaverton, OR), Bluett; Lauren Mackensie-Clark (Milwaukie, OR)
Assignee: Paragon Bioteck, Inc. (Portland, OR)
Application Number:14/080,771
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 8,859,623

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Paragon Bioteck PHENYLEPHRINE HYDROCHLORIDE phenylephrine hydrochloride SOLUTION/DROPS;OPHTHALMIC 203510-001 Mar 21, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial DILATION OF THE PUPIL ➤ Try a Free Trial
Paragon Bioteck PHENYLEPHRINE HYDROCHLORIDE phenylephrine hydrochloride SOLUTION/DROPS;OPHTHALMIC 203510-002 Mar 21, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial DILATION OF THE PUPIL ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Cantor Fitzgerald
Dow
Queensland Health
Healthtrust
Fish and Richardson
Chubb
Fuji
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.